Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc/ US8835561023 /
TMO
30/08/2024 16:44:10
|
Chg.
+0.72
|
Volume |
Bid16:44:27 |
Ask16:44:27 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
612.51USD
|
+0.12%
|
7,929 Turnover: 4.88 mill. |
612.17Bid Size: 203 |
621.35Ask Size: 220 |
234.44 bill.USD |
0.23% |
39.54 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
15.52 USD |
-12.56% |
EPS Diluted: |
15.45 USD |
-12.37% |
Revenues per Share: |
112.39 USD |
-3.55% |
Book Value per Share: |
122.53 USD |
7.26% |
Cash Flow per Share: |
22.04 USD |
-7.18% |
Dividend per Share: |
1.40 USD |
16.67% |
Total |
in mill. |
|
Revenues: |
42,857.00 USD |
-4.58% |
Net Income: |
5,995.00 USD |
-13.74% |
Operating Cash Flow: |
8,406.00 USD |
- |
Cash and Cash Equivalents: |
8,077.00 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
39.54 |
34.20 |
P/S Ratio: |
5.46 |
4.72 |
P/BV ratio: |
5.01 |
4.33 |
P/CF Ratio: |
27.84 |
24.08 |
PEG: |
-3.15 |
-2.72 |
Earnings Yield: |
2.53% |
2.92% |
Dividend Yield: |
0.23% |
0.26% |
Market Capitalization |
|
Market Capitalization: |
234.44 bill. USD |
202.4 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
381.72 mill. |
|
Profitability
Gross Profit Margin: |
- |
EBIT Margin: |
16.00% |
Net Profit Margin: |
13.99% |
Return on Equity: |
12.83% |
Return on Assets: |
6.07% |
Financial Strength
Liquidity I / Cash Ratio: |
57.64% |
Liquidity II / Quick Ratio: |
116.31% |
Liquidity III / Current Ratio: |
175.49% |
Debt / Equity Ratio: |
111.30% |
Dynam. Debt / Equity Ratio: |
618.63% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
31/12/2023 |
Accounting Standard: |
US GAAP |